FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Authority Hl7

42,405 resources

Type: Text:

By Version

By Realm

 

Start Prev Rows 27400 - 27600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealm
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1147.191Intra Aortic Balloon Pumpactive2022-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1147.193Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA)active2022-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1147.194Pressure Injury Deep Tissue Diagnosesactive2022-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1147.196Pressure Injury Stage 2, 3, 4, or Unstageable Diagnosesactive2022-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1147.197Present on Admission or Clinically Undeterminedactive2022-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1147.198Not Present On Admission or Documentation Insufficient to Determineactive2022-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.1DEXA Dual Energy Xray Absorptiometry, Bone Densityactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.11Bladder Cancer Staging Ta for Urology Careactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.12Bladder Cancer staging T1 for Urology Careactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.13Bladder Cancer staging Tis for Urology Careactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.15Carcinoma of urinary bladder, superficialactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.16Injection Leuprolide Acetateactive2017-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.17High grade bladder cancer Ta for Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.18Immunocompromised state for Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.19Systemic chemotherapy for urology careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.2Bladder Cancer in Situactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.20Corticosteroids for patients receiving Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.21Calcineurin inhibitors for patients receiving Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.23Immunomodulators for patients undergoing Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.24Monoclonal antibody for patient undergoing Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.28Radiotherapy for patients undergoing Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.29Plasmacytoid cell, morphologic abnormality for urology careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.3Bladder Cancer in Situactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.30Sarcomatoid, morphologic abnormality for Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.31Micropapillary, morphologic abnormality, for Urology Careactive2017-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.32Immunosuppressive Drugs for Urology Careactive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.38DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Careactive2017-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.39Mixed histology urothelial cell carcinoma for Urology Careactive2023-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.4BCG Bacillus Calmette Guerin, Ticeactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.40Cystectomy for Urology Careactive2017-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.44Unavailability of Bacillus Calmette Guerin for urology careactive2017-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.45Bladder Cancer for Urology Careactive2017-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.48Androgen deprivation therapy for Urology Careactive2021-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.5BCG Bacillus Calmette Guerin, Connaughtactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.52BCG Bacillus Calmette Guerin for Urology Careactive2020-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.53Cystectomy for Urology Careactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.54Acute Tuberculosis for Urology Careactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.55Cystectomy for Urology Careactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.56Active Tuberculosis for Urology Careactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.57Bladder Cancer Staging Tis for Urology Careactive2019-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.58Bladder Cancer Staging Tis for Urology Careactive2019-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.59Hospital Services for Urologyactive2023-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.6Peripheral DXA Scanactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.60Chemotherapy Agents for Advanced Canceractive2024-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.8Tuberculosis Diagnosis Prior to Urology Careactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1151.9Leukemia Diagnosis Prior to Urology Careactive2016-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.13Preventative Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.14Intensive Lifestyle Interventionsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.15Intensive Lifestyle Interventionsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.16Intensive Lifestyle Interventionsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.17Intensive lifestyle interventionsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.21Outpatient Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.22Outpatient Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.23Outpatient Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.24Outpatient Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.25Reason for No Intensive Lifestyle Interventionactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.27Type 2 Diabetes Diagnosesactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.28Type 2 Diabetes Diagnosesactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.29Type 2 Diabetes Diagnosesactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.30Prediabetes HbA1c Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.31Prediabetes HbA1c Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.32Prediabetes HbA1c Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.33Prediabetes Oral Glucose Tolerance Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.34Prediabetes Oral Glucose Tolerance Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.35Prediabetes Oral Glucose Tolerance Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.36Prediabetes Fasting plasma glucose or Plasma Glucose Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.37Prediabetes Fasting plasma glucose or Plasma Glucose Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.38Prediabetes Fasting plasma glucose or Plasma Glucose Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.4Glycemic Screening Testsactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.40Sickle Cell Disease with Vaso Occlusive Episodeactive2024-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.41Sickle Cell Disease with Vaso Occlusive Episodeactive2024-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.42Sickle Cell Disease with Vaso Occlusive Episodeactive2024-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.43Analgesics for Acute Painactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.49Medication Therapy Management Services for Essential Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.5Glycemic Screening Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.52Remote Physiologic Blood Pressure Monitoringactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.57Aldosterone Receptor Blocker for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.58Alpha Blocker for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.59Angiotensin Converting Enzyme Inhibitor for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.6Glycemic Screening Testsactive2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.60Angiotensin II Receptor Blocker for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.61Beta Blocker for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.62Calcium Channel Blocker Dihydropyridine for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.63Calcium Channel Blocker Non Dihydropyridine for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.64Central Acting for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.65Direct Renin Inhibitor for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.66Loop Diuretic for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.67Neuronal Blocking Agent for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.68Potassium Sparing Diuretic for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.69Thiazide Diuretic for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.7Preventative Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.70Vasodilator for Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.73Analgesics for Acute Pain (Non Parenteral Route)active2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.74Analgesics for Acute Pain (Parenteral Route)active2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.75Analgesics for Acute Pain Non Oral Enteral/Mucosal Routesactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.77Antihypertensive Medication Classesactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.78Medication Therapy Management Services for Essential Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.79Medication Therapy Management Services for Essential Hypertensionactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.8Preventative Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.84Renal Colicactive2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.85Renal Colicactive2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.86Renal Colicactive2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.88Direct LDL Cholesterolactive2025-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.89Calculated LDL Cholesterolactive2025-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1160.9Preventative Clinical Encountersactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.50Urinary retentionactive2017-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.51Urinary retentionactive2017-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.52Urinary retentionactive2017-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.65Morbid Obesityactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.66Morbid Obesityactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.67Morbid Obesityactive2018-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.68BMI greater than 40active2019-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1164.69Morbid Obesityactive2019-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.141Contraceptive Patch SNOMED Devicesactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.143Live Birth Delivery CPT Proceduresactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.144Contraceptive Patch SNOMED Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.145Contraceptive Patch SNOMED Findingsactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.146Contraceptive Patch ICD10CM Provision Encountersactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.147Contraceptive Patch ICD10CM Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.148Live Birth Delivery ICD10PCS Proceduresactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.149Contraceptive Patch HCPCS Devicesactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.15Chlamydia trachomatis and Neisseria Gonorrhoeae combined Testsactive2025-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.150Contraceptive Patch LOINCactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.152Live Birth Delivery Procedures SNOMED CTactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.153Contraceptive Ring SNOMED Surveillance Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.154Contraceptive Ring SNOMED Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.155Contraceptive Ring SNOMED Findingsactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.156Contraceptive Ring ICD10CM Provision Encountersactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.157Contraceptive Ring ICD10CM Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.159Contraceptive Ring HCPCS Devicesactive2022-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.160Contraceptive Ring LOINCactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.161Contraceptive Implant SNOMED Devicesactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.162Contraceptive Implant ICD10PCS Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.163Contraceptive Implant SNOMED Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.164Contraceptive Implant SNOMED Findingsactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.170Contraceptive Implant ICD10CM Provision Encountersactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.171Contraceptive Implant ICD10CM Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.173Contraceptive Implant HCPCS Devicesactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.174Contraceptive Patch Devicesactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.177Live Birth Delivery Proceduresactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.178Contraceptive Ring Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.180Contraceptive Implant CPT Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.181Injectable Contraceptive SNOMED Surveillance Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.182Injectable Contraceptive SNOMED Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.183Injectable Contraceptive SNOMED Findingsactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.185Injectable Contraceptive ICD10CM Provision Encountersactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.186Injectable Contraceptive ICD10CM Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.187Injectable Contraceptive HCPCS Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.188Injectable Contraceptive LOINCactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.189Oral Contraceptive Pill SNOMED Surveillance Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.190Oral Contraceptive Pill SNOMED Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.191Oral Contraceptive Pill SNOMED Findingsactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.193Oral Contraceptive Pill ICD10CM Provision Encountersactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.194Oral Contraceptive Pill ICD10CM Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.195Oral Contraceptive Pill HCPCS Provision Proceduresactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.196Oral Contraceptive Pill LOINCactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.197Injectable Contraceptive Provision Proceduresactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.198Injectable Contraceptive Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.199Oral Contraceptive Pill Provision Proceduresactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.200Oral Contraceptive Pill Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.201Contraceptive Implant Devicesactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.202Contraceptive Implant Provision Proceduresactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.203Contraceptive Implant Surveillanceactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.96Infecund Not for Contraceptive Reasons SNOMED Findingsactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.10ASN Screening Declinedactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.2Intracranial or Intraspinal surgeryactive2022-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.22Emergency Department Observationactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.27Mental Health Diagnosis without Substance Use Disordersactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.28Mental Health Diagnosis without Substance Use Disordersactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.29Bed Assignedactive2024-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.3Malignant Intracranial Neoplasm Groupactive2022-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.31Healthcare Agent & Power of Attorney Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.32Healthcare Agent and Power of Attorney Documentationactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.33Advance Directive Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.34Advance Directive Documentationactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.35Advance Directive Documentationactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.36Portable Medical Order(s) Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.37Portable Medical Order(s) Documentationactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.38Advance Care Planning Discussion Documentationactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.4Thrombolytic medicationsactive2021-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.40Advance Care Planning Documentationactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.41Advance Care Planning Documentationactive2024-09us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.42Healthcare Agent & Power of Attorney Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.43Advance Directive Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.45Advance Care Planning Documentationactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.46Advance Care Planning Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.47Portable Medical Order(s) Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.48Portable Medical Order(s) Documentationactive2024-10us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.49Intervention for Positive Utility Insecurity Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.5Allergy to thrombolyticsactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.50Intervention for Positive Utility Insecurity Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.51Intervention for Positive Transportation Insecurity Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.52Intervention for Positive Transportation Insecurity Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.53Intervention for Positive Housing Instability Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.54Intervention for Positive Housing Instability Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.55Intervention for Positive Homelessness Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.56Intervention for Positive Homelessness Screenactive2024-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.57Non Invasive Oxygen Therapy Device Codesactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.58Goals, preferences, and priorities for medical treatmentactive2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1170.6Thrombolytics Adverse Eventactive2025-02us